SCHEMBL5586618

SCHEMBL5586618

CCCc1cc(O)c(O)c(Cl)c1CCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.39
PTPN1 P18031 3/20 0.36
PRKCI P41743 1/20 0.36
PTPN11 Q06124 1/20 0.36
PGAM1 P18669 1/20 0.35
KDM4E B2RXH2 3/20 0.34
GLA P06280 3/20 0.34
GAA P10253 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
HIF1A Q16665 2/20 0.34
ALOX5 P09917 3/20 0.33
ERAP1 Q9NZ08 1/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590132 0.85 HPGD (0.47) KDM4EGLAGAAALDH1A1HPGD
SCHEMBL5587835 0.84 ALOX5 (0.47) HPGDALOX5NPC1MAPK1HTT
SCHEMBL5586878 0.82 ALOX5 (0.50) HPGDALOX5NPC1MAPK1HTT
SCHEMBL5589274 0.82 ALOX5 (0.50) HPGDALOX5NPC1MAPK1HTT
SCHEMBL5587612 0.82 ALOX5 (0.50) HPGDALOX5NPC1MAPK1HTT
SCHEMBL5589306 0.82 ALOX5 (0.50) HPGDALOX5NPC1MAPK1HTT
SCHEMBL5588161 0.82 ALOX5 (0.50) HPGDALOX5NPC1MAPK1HTT
SCHEMBL5589047 0.82 HMGCR (0.42) HMGCRPTPN1PRKCIPTPN11PGAM1
SCHEMBL5677726 0.78 HMGCR (0.40) HMGCRPTPN1PRKCIPTPN11PGAM1
SCHEMBL31545962 0.78 HMGCR (0.42) HMGCRPTPN1PRKCIPTPN11PGAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 HMGCR 3000/4885PTPN1 4679/4885PRKCI 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.